| Name | 5-bromo-4,6-dichloropyrimidin-2-amine |
|---|---|
| Synonyms |
5-bromo-4,6-dichloro-pyrimidin-2-ylamine
2-Amino-4,6-dichlor-5-brom-pyrimidin 2-amino-4,6-dichloro-5-bromo-pyrimidine 4,6-Dichlor-5-brom-2-amino-pyrimidin 5-Brom-4,6-dichlor-pyrimidin-2-ylamin 2-Pyrimidinamine,5-bromo-4,6-dichloro 2-AMINO-5-BROMO-4,6-DICHLOROPYRIMIDINE |
| Density | 2.054g/cm3 |
|---|---|
| Boiling Point | 419.434ºC at 760 mmHg |
| Molecular Formula | C4H2BrCl2N3 |
| Molecular Weight | 242.88900 |
| Flash Point | 207.467ºC |
| Exact Mass | 240.88100 |
| PSA | 51.80000 |
| LogP | 2.70930 |
| Index of Refraction | 1.67 |
| Storage condition | 2-8°C |
| Hazard Codes | Xi |
|---|---|
| HS Code | 2933599090 |
|
~88%
7781-26-2 |
| Literature: Cell Therapeutics, Inc. Patent: US2004/204386 A1, 2004 ; |
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |